From latency to neurodegeneration: varicella-zoster virus reactivation and dementia risk, with a focus on herpes zoster ophthalmicus
Journal of NeuroVirology · 2026-12 · 32 (6)
DOI: 10.1007/s13365-026-01351-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of NeuroVirology, online erschienen am 29.10.2026. Verfasst von Priya D Samalia und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Auckland, Auckland, New Zealand. dr.priyasamalia@gmail.com. Hauptthemen laut MEDLINE: Herpes Zoster Ophthalmicus, Virus Activation, Herpesvirus 3, Human, Dementia. Die Arbeit nennt 111 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Varicella zoster virus (VZV) reactivation has emerged as a potential contributor to dementia through vascular and inflammatory mechanisms, with herpes zoster ophthalmicus (HZO) representing a potentially higher-risk phenotype because of its association with cerebrovascular complications. This narrative review evaluated the epidemiological and mechanistic evidence linking VZV reactivation to cognitive decline. MEDLINE, PubMed, Embase, and the Cochrane Library were searched from inception to March 2026, supplemented by relevant publications identified during revision through October 2026, with emphasis on systematic reviews, large observational studies, quasi-experimental vaccination studies, and mechanistic investigations. Infection-based studies demonstrated heterogeneous findings, with modest associations between herpes zoster and subsequent dementia that frequently attenuated after adjustment for frailty and comorbidity. In contrast, vaccination studies, particularly natural experiments and quasi-experimental analyses, consistently reported lower dementia incidence following zoster immunisation, although causal interpretation and the magnitude of any protective effect remain uncertain. Observational studies suggest that antiviral therapy is associated with fewer short-term cerebrovascular complications, although its relationship with long-term cognitive outcomes remains uncertain. VZV-associated vasculopathy provides the strongest mechanistic rationale for a link with cognitive decline, whereas neuroinflammation, possible blood-brain barrier dysfunction, and interactions with neurodegenerative processes remain proposed pathways. Current evidence suggests that VZV reactivation may accelerate cognitive decline in susceptible individuals, but causality remains unproven. Further prospective studies are needed to clarify the contribution of VZV reactivation and the potential neuroprotective effects of vaccination and antiviral therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Auckland, Auckland, New Zealand. dr.priyasamalia@gmail.com.
- Te Whatu Ora Te Toka Tumai/Health New Zealand Auckland, Auckland, New Zealand. dr.priyasamalia@gmail.com.
- University of Otago, Dunedin, New Zealand. dr.priyasamalia@gmail.com.
- University of Auckland, Auckland, New Zealand.
- Te Whatu Ora Te Toka Tumai/Health New Zealand Auckland, Auckland, New Zealand.
Zitieren
APA
Samalia, P. D., Wang, R., Brickell, K., Netzler, N., Meyer, J., & Niederer, R. L. (2026). From latency to neurodegeneration: varicella-zoster virus reactivation and dementia risk, with a focus on herpes zoster ophthalmicus. Journal of NeuroVirology, 32(6). https://doi.org/10.1007/s13365-026-01351-5
Vancouver
Samalia PD, Wang R, Brickell K, Netzler N, Meyer J, Niederer RL. From latency to neurodegeneration: varicella-zoster virus reactivation and dementia risk, with a focus on herpes zoster ophthalmicus. Journal of NeuroVirology. 2026;32(6). doi:10.1007/s13365-026-01351-5
BibTeX
@article{Samalia2026,
author = {Samalia, Priya D and Wang, Raphael and Brickell, Kiri and Netzler, Natalie and Meyer, Jay and Niederer, Rachael L},
title = {From latency to neurodegeneration: varicella-zoster virus reactivation and dementia risk, with a focus on herpes zoster ophthalmicus},
journal = {Journal of NeuroVirology},
year = {2026},
volume = {32},
number = {6},
doi = {10.1007/s13365-026-01351-5}
}
EUVIMED